US74168J1016
US74168J1016
Prime Medicine, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.632.000 | 2.983.000 | 55.3% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 212.982.000 | 205.450.000 | 3.7% | |
| Operating Income | -208.350.000 | -202.467.000 | 2.9% |
| Pretax Income | -201.142.000 | -195.882.000 | 2.7% |
| Net Income Common Stockholders | -201.142.000 | -195.882.000 | 2.7% |
| -- | -- | -- | |
| -- | -- | -- |